UK Seeks To Make Clinical Trial Transparency 'Second Nature' For Sponsors
Executive Summary
The UK's Health Research Authority says there is no one reason why registration of clinical trials and reporting of results continue to fall short of requirements. It has issued proposals to bring about significant improvements.
You may also be interested in...
UK Explores Feasibility Of 100% Trial Registration Rates In Major Transparency Push
By the end of this year, the UK's Health Research Authority plans to have developed a strategy to drive improvements in research transparency, particularly when it comes to the registration of clinical trials and making results public.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.